StonvexLoading…
StonvexStonvexStonvexCore line items from CZFS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.34M | $9.88M | $7.58M | $4.81M |
Operating Income | $12.70M | $45.24M | $32.15M | $19.79M |
Net Income | $10.38M | $36.57M | $26.09M | $16.08M |
EPS (Diluted) | $2.16 | $7.62 | $5.44 | $3.35 |
Total Assets | $3.03B | $3.06B | $3.06B | $2.97B |
Total Liabilities | $2.68B | $2.73B | $2.73B | $2.65B |
Cash & Equivalents | $33.10M | $34.29M | $31.07M | $49.48M |
Free Cash Flow OCF − CapEx | $17.89M | $35.24M | $18.58M | $15.85M |
Shares Outstanding | 4.80M | 4.80M | 4.80M | 4.80M |